Gül BAYRAM, Abdoul NZEYIMANA, Semra UTKU, Mahmut ÜLGER, Gönül ASLAN, Erdoğan BERÇIN

BAZI MICHAEL TİPİ KATIM ÜRÜNLERİNİN SENTEZ ÇALIŞMASI VE ANTİMİKROBİYAL AKTİVİTELERİ

Amaç: Çoklu ilaca dirençli patojenik bakteri, mantar ve Mycobacterium tuberculosis enfeksiyonları dünya çapında giderek yaygınlaşmaya devam etmektedir. Organik kimyada, tiya-Michael tipi katım ayrıca biyoaktif bileşiklerin sentezinde önemli bir reaksiyondur. Bu çalışmada, 2-amino-3-[(2-nitro-1-fenilpropil)tiyo]propanoik asit Michael tip yeni katım ürünlerinin (IIa-IIg) sentezi ve antibakteriyel, antifungal ve antitüberküler aktivitelerinin araştırılması amaçlanmıştır.

STUDY ON SYNTHESIS AND ANTIMICROBIAL ACTIVITIES OF SOME MICHAEL-TYPE ADDITION COMPOUNDS

Objective: Multidrug-resistant pathogenic bacteria, fungi, and Mycobacterium tuberculosis infections continue to be increasingly widespread worldwide. In organic chemistry, the tiya-Michael type addition is also significant reaction in the synthesis of bioactive compounds. In this study, the aim is to synthesize the series of new Michael type addition products 2-amino-3-[(2-nitro-1-phenylpropyl)thio]propanoic acid (IIa-IIg) and to investigate their in vitro, antibacterial, antifungal and antitubercular activity.

Keywords:

Antibacterial activity, antifungal activity, antimycobacterial activity, β-methyl-β-nitrostyrene, Michael type addition,

PDF

___

1. Gajdacs, M. (2019). The concept of an ideal antibiotic: implications for drug design. Molecules, 24, 1–16. https://doi.org/10.3390/molecules24050892
2. Gajdacs, M., Albericio, F. (2019). Antibiotic resistance: from the bench to patients. Antibiotics, 8, 1–4. https://doi.org/10.3390/antibiotics8030129
3. Laxminarayan, R., Duse, A., Wattal, C., Zaidi, A.K.M, Wertheim, H.F.L., Sumpradit, N., Vieghe, E., Hara, G.L., Gould, I.M., Goossens, H., Greko, C., So, A.D., Bigdeli, M., Tomson, G., Woodhouse, W., Ombaka, E., Peralta, A.Q., Qamar, F.N., Mir, F., Kariuki, S., Bhutta, Z.A., Coates, A., Bergstrom, R., Wright, G.D., Brown, E.D., Cars, O. (2013). Antibiotic resistance-the need for global solutions. Lancet Infectious Disease, 13, 1057–1098. https://doi.org/10.1016/S1473-3099 (13)70318-9
4. World Health Organization Web Site. (2020). Retrieved January 14, 2021, from https://apps.who.int/iris/bitstream/handle/10665/336069/9789240013131-eng.pdf
5. Nielsen, S.F., Boesen, T., Larsen, M., Schonning, K., Kromann, H. (2004). Antibacterial chalcones- -bioisosteric replacement of the 4'-hydroxy group. Bioorganic & Medicinal Chemistry, 12, 3047– 3054. https://doi.org/10.1016/j.bmc.2004.03.071
6. Narasimhan, B., Belsare, D., Pharande, D., Mourya, V., Dhake, A. (2004). Esters, amides and substituted derivatives of cinnamic acid: synthesis, antimicrobial activity and QSAR investigations. European Journal of Medicinal Chemistry, 39, 827–834. https://doi.org/10.1016/j.ejmech.2004.06.013
7. Kaap, S., Quentin, I., Tamiru, D., Shaheen, M., Eger, K., Steinfelder, H.J. (2003). Structure activity analysis of the pro-apoptotic, antitumor effect of nitrostyrene adducts and related compounds. Biochemical Pharmacology, 65, 603–610. https://doi.org/10.1016/s0006-2952(02)01618-0
8. Mikami, Y., Yazawa, K., Maeda, A., Uno, J., Kubo, A., Saito, N., Kawakami, N. (1991). Antifungal activity of SL-1, a beta-nitrostyrene type pigment and its synthetic congeners. Journal of Antibiotics (Tokyo), 44, 1454–1456. https://doi.org/10.7164/antibiotics.44.1454
9. Wang, W.Y., Wu, Y.C., Wu, C.C. (2006). Prevention of platelet glycoprotein IIb/IIIa activation by 3,4- methylenedioxy-β-nitrostyrene, a novel tyrosine kinase inhibitor. Molecular Pharmacology, 70, 1380– 1389. https://doi.org/10.1124/mol.106.023986
10. Milhazes, N., Calheiros, R., Marques, M.P., Garrido, J., Cordeiro, M.N., Rodrigues, C., Cordeiro, M.N.D.S., Rodrigues, C., Quinteira, S., Novais, C., Peixe, L., Borges, F. (2006). β-Nitrostyrene derivatives as potential antibacterial agents: a structure-property-activity relationship study. Bioorganic & Medicinal Chemistry, 14, 4078–4088. https://doi.org/10.1016/j.bmc.2006.02.006
11. Hsieh, P.W., Chang, Y.T., Chuang, W.Y., Shih, H.C., Chiang, S.Z., Wu, C.C. (2010). The synthesis and biologic evaluation of anti-platelet and cytotoxic β-nitrostyrenes. Bioorganic & Medicinal Chemistry, 18, 7621–7627. https://doi.org/10.1016/j.bmc.2010.08.039
12. Cornell, H., Nguyen, T., Nicoletti, G., Jackson, N., Hügel, H. (2014). Comparisons of halogenated β-nitrostyrenes as antimicrobial agents. Applied Sciences, 4, 380–389. https://doi.org/10.3390/app4030380
13. Villar, J.A.F.P., Lima, F.T.D., Veber, C.L., Oliveira, A.R.M., Calgarotto, A.K., Marangoni, S., Silva, S.L. (2008). Synthesis and evaluation of nitrostyrene derivative compounds, new snake venom phospholipase A2 inhibitors. Toxicon, 51, 1467–1478. https://doi.org/10.1016/j.toxicon.2008.03.023.
14. Rahmani-Nezhad, S., Safavi, M., Pordeli M., Ardestani, S.K., Khosravani, L., Pourshojaei, Y., Emami, M. S., Foroumadi, A., Shafiee, A. (2014). Synthesis, in vitro cytotoxicity and apoptosis inducing study of 2-aryl-3-nitro-2H-chromene derivatives as potent anti-breast cancer agents. European Journal of Medicinal Chemistry, 86, 562–569. https://doi.org/10.1016/j.ejmech.2014.09.017
15. Gokce, M., Ozcelik, B., Bakır, G., Karaoğlu, T., Bercin, E., Noyanalpan, N. (2004). Antiviral and antimicrobial activities of new nitrobutane derivatives. Arzneimittel-Forschung, 54, 891–897. https://doi.org/10.1055/s-0031-1297045
16. Gokce, M., Utku, S., Bercin, E., Özcelik, B., Karaoglu, T., Noyanalpan, N. (2005). Synthesis and in vitro antimicrobial and cytotoxicity activities of 2-[(2-nitro-1-phenylalkyl) thio] benzoic acid derivatives. Turkish Journal of Chemistry, 29, 207–217.
17. Utku, S., Gokce, M., Ozcelik, B., Bercin, E. (2008). Evaluation of antimicrobial activity of 2-[(2- nitro-1-phenylalkyl)thiomethyl] benzimidazole derivatives. Turkish Journal of Pharmaceutical Sciences, 5, 107–116.
18. Shi, Y., Carroll, K.S. (2020). Activity-based sensing for site-specific proteomic analysis of cysteine oxidation. Accounts of Chemical Research, 53, 20–31. https://doi.org/ 10.1021/acs.accounts.9b00562
19. Piste, P. (2013). Cysteine-master antioxidant. International Journal of Pharmaceutical, Chemical and Biological Sciences, 3, 143–149. https://doi.org/10.3329/jbsp.v2i0.978
20. Sobhani, S., Rezazadeh, S. (2010). Michael addition reaction of thioacetic acid (AcSH) to conjugated alkenes under solvent- and catalyst-free conditions. Phosphorus, Sulfur, and Silicon and the Related Elements, 185, 2076–2084. https://doi.org/10.1080/10426500903496713
21. Pei, Q. L., Han, W. Y., Wu, Z. J., Zhang, X. M., & Yuan, W. C. (2013). Organocatalytic iastereoand enantioselective sulfa-Michael addition to α, β-disubstituted nitroalkenes. Tetrahedron, 69(26), 5367–5373. https://doi.org/10.1016/j.tet.2013.04.125
22. Clinical and Laboratory Standards Institute (CLSI) (formerly NCCLS). (2008). Performance Standards for Antimicrobial Susceptibility Testing 18th Informational Supplement. CLSI M100- S18, Clinical and Laboratory Standards Institute, 940 West Valley Road, Wayne, Pennsylvania, USA.
23. Clinical and Laboratory Standards Institute (CLSI) (formerly NCCLS). (2006). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeast Approved Standard, M27-A3, Clinical and Laboratory Standards Institute, 940 West Valley Road, Wayne, Pennsylvania, USA.
24. National Committee for Clinical Laboratory Standards. (2003). Susceptibility Testing of Mycobacteria, Nocardia, and Other Aerobic Actinomycetes: Approved Standard NCCLS Document M24-A. Wayne, Pennsylvania.
25. Nateche, F., Martin, A., Baraka, S., Palomino, J.C., Khaled, S., Portaels, F. (2006). Application of the resazurin microtitre assay for detection of multidrug resistance in Mycobacterium tuberculosis in Algiers. Journal of Medical Microbiology, 55, 857–860. https://doi.org/10.1099/jmm.0.46513-0
26. Bercin, E., Ozguçlu, S. (2005). The addition products of β-methyl-β-nitrostyrene derivatives with 2-mercaptomethylbenzimidazole and their NMR studies. Journal of Faculty of Pharmacy Gazi, 13, 133–142.
27. Demir-Ordu, O., Demir-Dundar, H., Ozkirimli, S. (2015). Stereochemical Investigations of diastereomeric N-[2-(aryl)-5-methyl-4-oxo-1,3-thiazlidine-3-yl]-pyridine-3-carboxamide by nuclear magnetic resonance spectroscopy (1D and 2D). International Journal of Spectroscopy, 1– 9. https://doi.org/10.1155/2015/609250
28. Shafiei, M., Peyton, L., Hashemzadeh, M., Foroumadi, A. (2020). History of the development of antifungal azoles: A review on structures, SAR, and mechanism of action. Bioorganic Chemistry, 104, 104240. https://doi.org/10.1016/j.bioorg.2020.104240
29. Pettit, R.K., Pettit, G.R., Hamel, E. Hamel, Hogan, F., Moser, B.R., Wolf, S., Pon, S., Chapuis, J.C., Schmidt, J.M. (2009). E-combretastatin and E-resveratrol structural modifications: Antimicrobial and cancer cell growth inhibitory β-E-nitrostyrenes. Bioorganic & Medicinal Chemistry, 17, 6606-6612. https://doi.org/10.1016/j.bmc.2009.07.076